Brookdale Senior Living Inc.

Where It Passes

Where It Falls Short

• Profitability0% pass✓ 3✗ 32▾

  No clean pass — all 16 investors flag at least one profitability criterion

  Positive EPS (10 years)7/24 years positive

  ✗GrahamPositive EPS every year for 10 years

  EPS Growth (3-yr avg, 10-yr window)

  ✗Graham>= 33% growth

  Net Income Positive (10+ years)5/24 years positive

  ✗BuffettPositive every year for 10+ years

  ROE (up to 5-year arithmetic mean)-37.4%

  ✗Buffett> 15% arithmetic mean (app rule)

  Operating Margin (10-yr trend)0.4% (latest)

  ✗BuffettStable or rising over 10 years

  Free Cash Flow Proxy$-93.9M

  ✗BuffettPositive and growing

  Earnings Variance (10-yr CoV)

  ✗BuffettCoV < 0.3

  Retained Earnings Effectiveness

  ✗Buffett$1 retained -> > $1 market value created

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  3-5 Year EPS CAGR

  ✗Lynch15-30% (Fast Grower); > 0% to pass

  ROEN/A (negative equity)

  ✗Lynch> 15%

  EBIT / Enterprise Value3.2%

  ✗Greenblatt> 10%

  Earnings Yield + ROC AssessmentEY=3.2%, ROC=4.9%

  ✗GreenblattBoth EY > 10% and ROC > 25%

  Net Income / Total Assets-4.41%

  ✗PiotroskiROA > 0

  ROA Change YoY-3.19% -> -4.41% (delta: -1.23%)

  ✗PiotroskiCurrent ROA > Prior ROA

  (CFO / Total Assets) vs ROACFO/Assets=3.66%, ROA=-4.41%

  ✓PiotroskiCFO/Assets > ROA

  Gross Margin Change YoY25.6% -> 26.2%

  ✓PiotroskiImproved YoY

  Pre-Tax Income / Revenue-1.2%

  ✗Dreman>= 8%

  Net Income / Shareholders' Equity

  ✗Dreman> 12%

  Margin of Safety

  ✗PabraiP/B < 1.5 or P/E < 15

  Return on Equity-60.9% (3-yr avg)

  ✗AkreROE > 20% (3-year avg)

  Discount to Intrinsic ValueN/A (negative normalized EPS)

  ✗Marks>= 20% below intrinsic value

  Positive Net Income Frequency5/22 years positive

  ✗MarksPositive net income in >= 7 of last 10 years

  Operating Income / Revenue6.8%

  ✗Ackman>= 15%

  Net Income / Shareholders Equity

  ✗Ackman>= 15%

  5-Year EPS CAGR

  ✗Templeton> 0% (5-year EPS CAGR)

  Operating Margin Trend0.6% (2023) -> 0.4% (2025)

  ✗TempletonNon-negative operating-margin trend over 3 years

  Revenue growth vs. gross and operating margin trendgross margin 24.8% -> 26.2%, operating margin 0.6% -> 0.4%

  ✗SleepRevenue rising; gross margin flat or falling; operating margin holding

  Net income / market capitalization-1.71%; #3515/6340 (top 55.4%)

  ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section

  Gross profit / total assets+13.74%; #2510/3702 (top 67.8%)

  ✗AsnessTop 30% of eligible cross-section

  Net income / positive book equity

  ✗AsnessTop 30% of eligible cross-section

  Negative 5-year standard deviation of ROA-0.0098; #813/5884 (top 13.8%)

  ✓AsnessTop 30% of eligible cross-section

  3-5 Year Diluted EPS CAGR57.7% over 5 years

  ✗Neff7%-20% annualized

  Positive Diluted-EPS Years1/10 years positive

  ✗Schloss>= 70% positive over 5-10 observed years (app rule)
• Debt & Leverage0% pass✗ 15▾

  All 12 investors flag BKD's debt & leverage

  LT Debt vs Net Current AssetsLT Debt $4.3B vs NCA $26.7M

  ✗GrahamLT Debt <= Net Current Assets

  Debt/Equity & Interest CoverageD/E: N/A (negative equity), IC: 0.1x

  ✗BuffettD/E < 0.5 AND Interest Coverage > 5x

  Total Debt / EquityN/A (negative equity)

  ✗Lynch< 0.33

  Cash - Long-term Debt$-4.0B

  ✗LynchPositive preferred

  LT Debt / Total Assets Change63.48% -> 70.81%

  ✗PiotroskiDecreased YoY

  Current Assets / Current Liabilities1.05

  ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)

  Total Debt / Shareholders' Equity

  ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x

  Debt LevelsN/A (non-positive equity)

  ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3

  Interest Coverage & Debt/EBITDAIC=0.1x, D/EBITDA=11.2x

  ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x

  Total Debt / Shareholders Equity

  ✗Ackman<= 1.0

  Negative debt-to-equity (higher means less debt)

  ✗AsnessTop 30% of eligible cross-section
• Valuation0% pass✗ 28▾

  All 13 investors flag BKD's valuation

  Price / 3-yr avg EPS

  ✗Graham<= 15x

  Price-to-Book Ratio

  ✗Graham<= 1.5x

  P/E x P/B

  ✗Graham<= 22.5

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  EBIT / Enterprise Value3.2%

  ✗Greenblatt> 10%

  Earnings Yield + ROC AssessmentEY=3.2%, ROC=4.9%

  ✗GreenblattBoth EY > 10% and ROC > 25%

  Price / EPS

  ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)

  Price / (CFO / Shares)10.0x

  ✗Dreman< 8x

  Price / Book Value per ShareN/A (negative BVPS)

  ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)

  Valuation ReasonablenessOE Yield=-4.3%

  ✗MungerP/E < 25 or Owner Earnings Yield > 5%

  P/E or FCF YieldFCF Yield=0.8%

  ✗PabraiP/E < 15 or FCF Yield > 10%

  P/B or P/E vs. Historical Average

  ✗MarksP/E < 15 or P/B < 2.0

  Discount to Intrinsic ValueN/A (negative normalized EPS)

  ✗Marks>= 20% below intrinsic value

  Price / FCF per Share132.1x

  ✗Ackman<= 25

  Price vs. Trailing Low198% of trailing low ($4.63)

  ✗Templeton<= 120% of trailing low (certified split-adjusted live window)

  Net income / market capitalization-1.71%; #3515/6340 (top 55.4%)

  ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section

  Positive book equity / market capitalization-0.0179; #5381/6449 (top 83.4%)

  ✗AsnessTop 30% of eligible cross-section

  Price / Diluted EPS

  ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)

  (EPS CAGR % + Dividend Yield %) / P/E

  ✗Neff> 0.7 (Neff's published traditional edge)

  Price / Tangible Book Value per ShareN/A (non-positive TBVPS)

  ✗SchlossP/TBV <= 1.00x (app cutoff)

  Book Value per Share Change-104.4%

  ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)

  Revenue / market capitalization+1.3441; #1452/5247 (top 27.7%)

  ✗OshaughnessyTop 10% of eligible cross-section

  (Operating cash flow - capex) / market capitalization+0.66%; #2442/4519 (top 54.0%)

  ✗OshaughnessyTop 10% of eligible cross-section

  Trailing six-month price return through the evaluation date-32.32%; #4510/6202 (top 72.7%)

  ✗OshaughnessyTop 10% of eligible cross-section
• Growth0% pass✓ 1✗ 12▾

  No clean pass — all 8 investors flag at least one growth criterion

  EPS Growth (3-yr avg, 10-yr window)

  ✗Graham>= 33% growth

  Basic earnings-growth PEG (dividends excluded)

  ✗Lynch< 1.0 (ideally < 0.5)

  3-5 Year EPS CAGR

  ✗Lynch15-30% (Fast Grower); > 0% to pass

  Inventory Growth vs Revenue GrowthN/A (no inventory)

  ✓LynchInventory growth < Revenue growth

  EPS Growth Direction

  ✗DremanPositive over recent years

  EPS CAGR

  ✗Dreman> 5% annualized

  Positive Net Income Frequency5/22 years positive

  ✗MarksPositive net income in >= 7 of last 10 years

  3yr Median Revenue Growth3.6%

  ✗Ackman>= 5%

  Positive EPS Growth Frequency1/5 years with positive EPS growth

  ✗AckmanPositive EPS growth in >= 3 of last 5 years

  5-Year EPS CAGR

  ✗Templeton> 0% (5-year EPS CAGR)

  Revenue growth vs. gross and operating margin trendgross margin 24.8% -> 26.2%, operating margin 0.6% -> 0.4%

  ✗SleepRevenue rising; gross margin flat or falling; operating margin holding

  5-year Revenue CAGR-2.0%

  ✗SleepCAGR > 7%

  3-5 Year Diluted EPS CAGR57.7% over 5 years

  ✗Neff7%-20% annualized
• Valuation models0% pass✗ 3▾

  BKD overvalued: all 3 models price fair value below $9.17 (median $0.87)

  Greenblatt fair value$0.87

  ✗Greenblatt-954.0% margin vs $9.17

  Munger fair value$0.59

  ✗Munger-1454.2% margin vs $9.17

  Ackman fair value$1.07

  ✗Ackman-757.0% margin vs $9.17
• Verdicts7% pass✓ 1✗ 14▾

  Split decision: 13 FAIL · 2 NEUTRAL · 1 PASS

  Overall verdict

  ✗GrahamFAIL (1/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)✗GreenblattRank #1667✓PiotroskiPASS (F-Score 5)✗DremanFAIL (1/11)✗MungerFAIL (0/4)✗PabraiFAIL (0/3)✗AkreFAIL (1/6)✗MarksFAIL (1/5)✗AckmanFAIL (2/9)✗TempletonFAIL (1/8)✗SleepFAIL (2/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (1/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked)
• Efficiency13% pass✓ 2✗ 9▾

  7 of 8 flag BKD's efficiency — Graham, Buffett, Greenblatt +4 more

  Current Ratio1.05

  ✗Graham>= 2.0

  ROIC (3-5 yr avg)-0.7%

  ✗Buffett> 10%

  ROIC - WACC-10.7%

  ✗BuffettPositive (WACC = 10%)

  EBIT / (NWC + Net Fixed Assets)4.9%

  ✗Greenblatt> 25%

  Current Ratio Change YoY0.88 -> 0.98

  ✓PiotroskiIncreased YoY

  Revenue / Total Assets Change YoY0.49x -> 0.54x

  ✓PiotroskiImproved YoY

  Current Assets / Current Liabilities1.05

  ✗Dreman> 1.5

  Return on Invested Capital3.7%

  ✗Munger> 15%

  ROIC (high and growing)FY2023: ROIC=0.4%; FY2024: ROIC=0.9%; FY2025: ROIC=0.3%

  ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each

  Reinvestment Rate x ROICN/A (non-positive net income)

  ✗AkreReinvestment Rate * ROIC > 10%

  ROIC (5-year)0/5 years above 12% (latest 0.3%)

  ✗SleepROIC > 12% in a majority of years
• Cash Flow40% pass✓ 5✗ 7▾

  6 of 10 flag BKD's cash flow — Buffett, Lynch, Dreman +3 more

  Free Cash Flow Proxy$-93.9M

  ✗BuffettPositive and growing

  FCF Positive and Growing$14.5M

  ✗LynchPositive and growing

  Operating Cash Flow$218.0M

  ✓PiotroskiCFO > 0

  (CFO / Total Assets) vs ROACFO/Assets=3.66%, ROA=-4.41%

  ✓PiotroskiCFO/Assets > ROA

  Price / (CFO / Shares)10.0x

  ✗Dreman< 8x

  P/E or FCF YieldFCF Yield=0.8%

  ✗PabraiP/E < 15 or FCF Yield > 10%

  FCF Positive10/19 years FCF positive

  ✓MarksPositive FCF in majority of recent years

  (OCF - CapEx) / Market Cap0.7%

  ✗Ackman>= 4%

  Price / FCF per Share132.1x

  ✗Ackman<= 25

  Positive Operating Cash Flow frequency22/23 years positive

  ✓SleepPositive OCF in >= 70% of available years

  Operating Cash Flow - Capital Expenditures$14.5M

  ✓Neff> $0 (app proxy for a strong fundamental case)

  (Operating cash flow - capex) / market capitalization+0.66%; #2442/4519 (top 54.0%)

  ✗OshaughnessyTop 10% of eligible cross-section